SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-021135
Filing Date
2024-02-27
Accepted
2024-02-27 16:11:05
Documents
80
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K grph-20231231.htm   iXBRL 10-K 3016129
2 EX-10.27 grph-ex10_27.htm EX-10.27 31141
3 EX-21.1 grph-ex21_1.htm EX-21.1 2161
4 EX-23.1 grph-ex23_1.htm EX-23.1 3502
5 EX-31.1 grph-ex31_1.htm EX-31.1 17039
6 EX-32.1 grph-ex32_1.htm EX-32.1 10141
  Complete submission text file 0000950170-24-021135.txt   11277111

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT grph-20231231.xsd EX-101.SCH 1850302
82 EXTRACTED XBRL INSTANCE DOCUMENT grph-20231231_htm.xml XML 1626516
Mailing Address 611 GATEWAY BLVD, SUITE 120 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD, SUITE 120 SOUTH SAN FRANCISCO CA 94080 (650) 484-0886
Graphite Bio, Inc. (Filer) CIK: 0001815776 (see all company filings)

IRS No.: 844867570 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40532 | Film No.: 24686798
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)